Age-related macular degeneration (AMD) is the third most common cause of visual impairment worldwide, and the number of people with AMD is expected to increase by approximately 40% between 2020 and 2040.
1 Early AMD is clinically characterized by the presence of yellowish drusen,
2 which are accumulations of extracellular material between the retinal pigment epithelium–basal lamina and the inner collagenous layer of the Bruch membrane. A specific category of drusen called reticular pseudodrusen (RPD),
3 or subretinal drusenoid deposits,
4 corresponds to drusen-like, granular hyperreflective material located not beneath but above the retinal pigment epithelium.
5 Early identification of RPD is important because they have been shown to be a major risk factor of advanced AMD, compared with other drusen,
6 with a cumulative incidence risk ranging from 33.9% to 54.5% at 5 years.
7,8